Dergiler / Turkish journal of nephrology (Online) / 2022 / Cilt: 31 - Sayı: 3

COVID-19 Among Hospitalized Patients with Kidney Disease: Experience at a US Midwestern Academic Medical Center

Sayfa
230–236
Yayın Tarihi
2022-11-02
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Identifying those at the highest risk for adverse outcomes may direct preventative strategies including counseling on vaccination.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: We sought to characterize the clinical profiles and outcomes of patients with coronavirus disease 2019 and comorbid kidney disease hospitalized at a U.S. urban, Midwestern tertiary care hospital.
📊
Temel Bulgular & Veri:Methods: In this single-center observational study, we describe 205 patients with acute kidney injury (n = 98), dialysisdependent chronic kidney disease stage 5 (n = 54), or kidney transplant (n = 53), admitted during the first surge of the local pandemic, from March 19, 2020, to July 31, 2021.
💡
Sonuç & Katkı:Identifying those at the highest risk for adverse outcomes may direct preventative strategies including counseling on vaccination.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: We sought to characterize the clinical profiles and outcomes of patients with coronavirus disease 2019 and comorbid kidney disease hospitalized at a U.S. urban, Midwestern tertiary care hospital. Methods: In this single-center observational study, we describe 205 patients with acute kidney injury (n = 98), dialysisdependent chronic kidney disease stage 5 (n = 54), or kidney transplant (n = 53), admitted during the first surge of the local pandemic, from March 19, 2020, to July 31, 2021. Results: Most patients in the cohort were African American (acute kidney injury, 51%; dialysis-dependent chronic kidney disease stage 5, 82%; kidney transplant, 62%), and obesity was common (acute kidney injury, 53%; dialysis-dependent chronic kidney disease stage 5, 44%; kidney transplant, 59%). Mechanical ventilation was required in 50% of the acute kidney injury, 22% of the dialysis-dependent chronic kidney disease stage 5, and 13% of the kidney transplant recipients. Nearly half of the acute kidney injury patients (46%) died and 49% required kidney replacement therapy, while in-hospital mortality was 24% in the dialysis-dependent chronic kidney disease stage 5 patients and 9% in the kidney transplant recipients. Logistic regression analysis identified older age and patient group as leading correlates of mortality, with lower death risk in kidney transplant (24%; odds ratio (OR), 0.17; 95% CI 0.06-0.47) and dialysis-dependent chronic kidney disease stage 5 (9%; OR, 0.36; 95% CI 0.16-0.78) patients compared to acute kidney injury patients (46%). Obesity was associated with a 5-fold increased mortality risk in the coronavirus disease 2019 patients with acute kidney injury (OR, 5.32; 95% CI 1.41- 20.03) but not in dialysis-dependent chronic kidney disease stage 5 or kidney transplant patients. Conclusions: During the first surge of the pandemic, kidney patients hospitalized with coronavirus disease 2019 experienced high mortality, especially those with acute kidney injury, older age, and obesity. Identifying those at the highest risk for adverse outcomes may direct preventative strategies including counseling on vaccination.

🔖

Bu Makaleye Atıf Yap

ÇALIŞKAN, Y., RUB, F. A. A., GROLL, T., PAHLAVANI, S., SCHNELL, A., MEMON, A. A., ELEWA, U., PHILIPNERI, M., MIYATA, K., VO, T., MOSMAN, A., EDWARDS, J. C., LENTINE, K. L. (2022). COVID-19 Among Hospitalized Patients with Kidney Disease: Experience at a US Midwestern Academic Medical Center. Turkish journal of nephrology (Online), Cilt: 31 - Sayı: 3, 230–236. https://ajindex.com/articles/612812

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Akalin E, Azzi Y, Bartash R, et al. Covid-19 and kidney transplantation. N Engl J Med. 2020
  2. 382(25):2475-2477. [CrossRef] İ 2. Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M. COVID19 infection in kidney transplant recipients. Kidney Int. 2020
  3. 97(6):1076-1082. [CrossRef] 3. Karaca-Mandic P, Georgiou A, Sen S. Assessment of COVID-19 hospitalizations by race/ethnicity in 12 states. JAMA Intern Med. 2021
  4. 181(1):131-134. [CrossRef] 4. Lentine KL, Mannon RB, Josephson MA. Practicing With uncertainty: kidney transplantation During the COVID-19 pandemic. Am J Kidney Dis. 2021
  5. 77(5):777-785. [CrossRef] 5. Kapp ME, Fogo AB, Roufouse C, et al. Renal considerations in COVID-19: Part 1 Biology, Pathology and Pathophysiology. ASAIO J. 2021. [CrossRef] 6. Lentine KL, Vest LS, Schnitzler MA, et al. Survey of US living kidney donation and transplantation practices in the COVID-19 era. Kidney Int Rep. 2020
  6. 5(11):1894-1905. [CrossRef] 7. Salvalaggio PR, Ferreira GF, Caliskan Y, et al. An International survey on living kidney donation and transplant practices during the COVID-19 pandemic. Transpl Infect Dis. 2021
  7. 23(2):e13526. [CrossRef] 8. Cowger TL, Davis BA, Etkins OS, et al. Comparison of weighted and unweighted population data to assess inequities in coronavirus disease 2019 deaths by race/ethnicity reported by the US Centers for Disease Control and Prevention. JAMA Netw Open. 2020
  8. 3(7):e2016933. [CrossRef] 9. Udomkarnjananun S, Kerr SJ, Townamchai N, et al. Mortality risk factors of COVID-19 infection in kidney transplantation recipients: a systematic review and meta-analysis of cohorts and clinical registries. Sci Rep. 2021
  9. 11(1):20073. [CrossRef] 10. Hilbrands LB, Duivenvoorden R, Vart P, et al. COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. 2020
  10. 35(11):1973- 1983. [CrossRef] 11. Kidney int Suppl (2011)-Section 2: AKI Definition. Kidney Int Suppl (2011). 2012
  11. 2(1):19-36. [CrossRef] 12. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020
  12. 97(5):829-838. [CrossRef] 13. Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020
  13. 69(15):458-464. [CrossRef] 14. Cai X, Wu G, Zhang J, Yang L. Risk factors for acute kidney injury in adult pa